Single pill combination therapy for hypertension: New evidence and new challenges: Combination Therapy for

Martin Rosas-Peralta1, Giuseppe Mancia2, Miguel Camafort3

  • 1GREHTA (Group of Experts in Hypertension). México.

Insights

Hypertension (HTN) management requires careful cardiovascular risk stratification. This study proposes a practical clinical approach to guide pharmacological therapy, emphasizing individualized treatment strategies for better patient outcomes.

Area of Science:

  • Cardiology
  • Internal Medicine
  • Public Health

Background:

  • Hypertension (HTN) is a major global risk factor for cardiovascular events and mortality, affecting approximately 30% of adults worldwide.
  • Current cardiovascular risk stratification scales have limitations, necessitating practical clinical approaches for effective management.

Purpose of the Study:

  • To discuss the challenges in cardiovascular risk stratification for hypertensive patients.
  • To propose a practical clinical approach for determining cardiovascular risk and guiding pharmacological therapy.
  • To provide recommendations for primary care physicians in managing hypertension.

Main Methods:

  • The study reviews existing risk stratification methods and their limitations.
  • It outlines a clinical approach based on risk factors, blood pressure elevation, target organ damage, and cardiovascular event history.
  • It discusses current dual and potential triple therapy recommendations.

Main Results:

  • A practical clinical approach integrating multiple factors is presented as a viable alternative to complex risk scales.
  • The need for dual therapy is highlighted, with a recommendation for initiating triple therapy in high-risk patients with severe hypertension.
  • The article aims to equip primary care physicians with tools for effective hypertension management.

Conclusions:

  • Effective cardiovascular risk stratification is essential for optimizing hypertension treatment.
  • A simplified clinical approach can aid primary care physicians in making timely therapeutic decisions.
  • Individualized treatment strategies, including potential triple therapy, are crucial for managing high-risk hypertensive patients.

Related Concept Videos

Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
48
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
4.8K
Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
107
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
54
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
893
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
41